Breast Implants
Conditions
Brief summary
The purpose of this study is to evaluate safety and effectiveness of Light Weight Breast Implant (LWBI) in breast augmentation.
Detailed description
This is a Single-center. The purpose of the study is to evaluate safety and effectiveness of LWBI in breast augmentation.
Interventions
Light Weight Breast Implants
Sponsors
Study design
Eligibility
Inclusion criteria
* Genetic women at ages 18 to 65 seeking breast enlargement * Signed informed consent * Agreement to complete all required follow up visits * A medically acceptable candidate * Sufficient breast tissue for proper implant coverage (≥20 mm by pinch test)
Exclusion criteria
* Patients with active infection anywhere in their body * Women who are currently pregnant or nursing * Insufficient tissue covering in the prospective area of implantation (e.g. after preceding breast reduction), radiation damage or reduced vascularization * Abscesses, malignant tumors(cancer or recurrent metastases), advanced fibrocystic diseases * Patients with a history of psychiatric treatment * Patients that been implanted with any silicone implant (e.g. silicone artificial joints, facial implants) * Expected allergies or extraordinary immune response to implants * Wound healing impairments or heavy burn scars * Existing costal injuries * The Patient Participated in an investigational trial within 30 days of enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No reoperation | during 6 months follow up period |
Secondary
| Measure | Time frame |
|---|---|
| Duration for all adverse events (AEs) on per patient and per implant basis will be recorded and analyzed. | 6 month |
Countries
Israel